Prognostic value of serum paraoxonase and arylesterase activity in patients with sepsis

Journal of International Medical Research

Volumn 41, Issue 3, 2013, Pages 681-687

  Li, Yunhui ^a   Zhai, Rubo ^a   Li, Haifeng ^a   Mei, Xu ^a   Qiu, Guangbin ^a  

^a No 202 Hospital of PLA   (China)

Author keywords

Oxidative stress; prognosis; sepsis; serum

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE;

ADULT; AGED; ARTICLE; ARYLDIALKYLPHOSPHATASE BLOOD LEVEL; ARYLESTERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PREDICTION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL RATE; SURVIVAL TIME;

OXIDATIVE STRESS; PROGNOSIS; SEPSIS; SERUM;

ADULT; AGED; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEPSIS; SURVIVAL ANALYSIS;

EID: 84887398175     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513483412     Document Type: Article

References (34)

1. Taccone FS,Laterre PF,Dugernier T,et al.Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.Crit Care. 2010;14:R126-R126.
2. Lever A,Mackenzie I.Sepsis: definition, epidemiology, and diagnosis.BMJ. 2007;335:879-883.
3. Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000.N Engl J Med. 2003;348:1546-1554.
4. Hillas G,Vassilakopoulos T,Plantza P,et al.C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia.Eur Respir J. 2010;35:805-811.
5. Chen SJ,Chao TF,Chiang MC,et al.Prediction of patient outcome from Acinetobacter baumannii bacteremia with Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores.Intern Med. 2011;50:871-877.
6. Crimi E,Sica V,Williams-Ignarro S,et al.The role of oxidative stress in adult critical care.Free Radic Biol Med. 2006;40:398-406.
7. Pinsky MR.Dysregulation of the immune response in severe sepsis.Am J Med Sci. 2004;328:220-229.
8. Cepinskas G,Wilson JX.Inflammatory response in microvascular endothelium in sepsis: role of oxidants.J Clin Biochem Nutr. 2008;42:175-184.
9. Gogos CA,Drosou E,Bassaris HP,et al.Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.J Infect Dis. 2000;181:176-180.
10. Victor VM,De la Fuente M.Several functions of immune cells in mice changed by oxidative stress caused by endotoxin.Physiol Res. 2003;52:789-796.
11. Goode HF,Cowley HC,Walker BE,et al.Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction.Crit Care Med. 1995;23:646-651.
12. Galley HF,Davies MJ,Webster NR.Xanthine oxidase activity and free radical generation in patients with sepsis syndrome.Crit Care Med. 1996;24:1649-1653.
13. Chuang CC,Shiesh SC,Chi CH,et al.Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis.Crit Care. 2006;10:R36-R36.
14. Berger MM,Chioléro RL.Antioxidant supplementation in sepsis and systemic inflammatory response syndrome.Crit Care Med. 2007;35:S584-S590.
15. Andrades ME,Ritter C,Dal-Pizzol F.The role of free radicals in sepsis development.Front Biosci (Elite Ed). 2009;1:277-287.
16. Dal-Pizzol F.Alternative activated macrophage: a new key for systemic inflammatory response syndrome and sepsis treatment?.Crit Care Med. 2004;32:1971-1972.
17. Cebeci E,Oner FA,Usta M,et al.Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism.Acta Biomed. 2011;82:214-222.
18. Yesilova Y,Turan E,Ucmak D,et al.Reduced serum paraoxonase-1 levels in vitiligo: further evidence of oxidative stress.Redox Rep. 2012;17:214-218.
19. Cebeci E,Alibaz-Oner F,Usta M,et al.Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinical hypothyroidism.J Investig Med. 2012;60:23-28.
20. Draganov D,Teiber J,Watson C,et al.PON1 and oxidative stress in human sepsis and an animal model of sepsis.Adv Exp Med Biol. 2010;660:89-97.
21. Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.Chest. 1992;101:1644-1655.
22. Knaus WA,Draper EA,Wagner DP,et al.APACHE II: a severity of disease classification system.Crit Care Med. 1985;13:818-829.
23. Vincent JL,Moreno R,Takala J,et al.The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.Intensive Care Med. 1996;22:707-710.
24. Eckerson HW,Wyte CM,La Du BN.The human serum paraoxonase/arylesterase polymorphism.Am J Hum Genet. 1983;35:1126-1138.
25. Haagen L,Brock A.A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate.Eur J Clin Chem Clin Biochem. 1992;30:391-395.
26. Chen RM,Chen TG,Chen TL,et al.Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages.Ann N Y Acad Sci. 2005;1042:262-271.
27. Yavuz L,Aynali G,Aynali A,et al.The effects of adjuvant immunoglobulin M-enriched immunoglobulin therapy on mortality rate and renal function in sepsis-induced multiple organ dysfunction syndrome: retrospective analysis of intensive care unit patients.J Int Med Res. 2012;40:1166-1174.
28. von Dessauer B,Bongain J,Molina V,et al.Oxidative stress as a novel target in pediatric sepsis management.J Crit Care. 2011;26:103-103.
29. Schulte J,Struck J,Köhrle J,et al.Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis.Shock. 2011;35:460-465.
30. Otocka-Kmiecik A,Orłowska-Majdak M.The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase.Postepy Hig Med Dosw (Online). 2009;63:668-677.
31. Aviram M,Rosenblat M,Bisgaier CL,et al.Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.J Clin Inves. 1998;101:1581-1590.
32. Galley HF.Oxidative stress and mitochondrial dysfunction in sepsis.British J Anaesth. 2011;107:57-64.
33. Wu A,Hinds CJ,Thiemermann C.High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications.Shock. 2004;21:210-221.
34. Novak F,Vavrova L,Kodydkova J,et al.Decreased paraoxonase activity in critically ill patients with sepsis.Clin Exp Med. 2010;10:21-25.